| Literature DB >> 35392367 |
Haichen Wang1,2, Jia Li2,3, Changhang Min1,2, Fengjun Xia1,2, Mengli Tang1,2, Jun Li1,2, Yongmei Hu1,2, Mingxiang Zou1,2.
Abstract
Purpose: Due to the extensive consumption of silver-containing compound, silver resistance spreads among gram-negative pathogens and is regarded as a great public problem. In this study, we investigated silver resistance mechanisms and antibiotic resistance genes co-harbored with sil operon among gram-negative pathogens isolated from wound samples.Entities:
Keywords: antibiotic resistance gene; gram negative pathogen; sil operon; silver resistance; whole-genome sequencing
Year: 2022 PMID: 35392367 PMCID: PMC8982571 DOI: 10.2147/IDR.S358730
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Overall Identities of sil Genes Compared with pMG101
| Strains | |||
|---|---|---|---|
| WHC9 | 95.05% | 98.69% | 91.45% |
| WHC10 | 98.90% | 98.40% | 100.00% |
| WHC12 | 95.05% | 98.69% | 91.45% |
| WHC16 | 95.05% | 98.69% | 91.45% |
| WHC21 | 94.72% | 93.01% | 91.92% |
| WHC31 | 94.48% | 94.03% | 96.06% |
| WHC41 | 95.05% | 98.69% | 91.52% |
| WHC49 | 94.11% | 92.58% | 90.51% |
| WHC57 | 95.09% | 98.54% | 91.45% |
| WHC61 | 97.72% | 98.54% | 100.00% |
| WHC65 | 94.91% | 92.87% | 99.77% |
| WHC135 | 95.76% | 92.72% | 100.00% |
| WHC151 | 94.11% | 92.58% | 90.51% |
| WHC152 | 94.48% | 94.03% | 96.06% |
| WHC154 | 95.83% | 98.11% | 99.07% |
| WHC160 | 94.98% | 94.03% | 96.06% |
| WHC161 | 94.11% | 92.58% | 90.51% |
| WHC167 | 94.85% | 92.87% | 100.00% |
| WHC171 | 94.91% | 92.87% | 100.00% |
| WHC179 | 95.05% | 98.69% | 91.45% |
| WHC181 | 95.85% | 98.11% | 99.07% |
| WHC182 | 94.18% | 93.16% | 91.92% |
| WHC190 | 95.86% | 92.87% | 100.00% |
| WHC192 | 94.11% | 92.58% | 90.51% |
Antibiotic Resistance Genes and Plasmid Inc Type Among Gram-Negative Pathogens Harboring sil Operon
| Isolate | Antibiotic Resistance Genes | Plasmid Inc Types |
|---|---|---|
| WHC9 | IncFIB(K), IncFII(K), IncM2, IncQ1 | |
| WHC10 | IncHI2A | |
| WHC12 | IncFIB(K), IncFII(K), IncM2, IncQ1 | |
| WHC16 | IncFIB(K), IncFII(K), IncM2, IncQ1 | |
| WHC21 | IncFIB(K) | |
| WHC31 | IncFIB(K), IncFII(K) | |
| WHC41 | IncFIB(K) | |
| WHC49 | repB | |
| WHC57 | IncFIB, IncFII | |
| WHC61 | No plasmid found | |
| WHC65 | No plasmid found | |
| WHC135 | IncHI2A, IncX3 | |
| WHC151 | IncFII, IncHI1B, IncR, repB, ColRNAI | |
| WHC152 | IncFIB, IncFII(K), IncI1-I, IncN, Col156 | |
| WHC154 | IncFIB, IncHI2A, IncX3 | |
| WHC160 | IncFIB(K), IncFII(K) | |
| WHC161 | IncHI1B, repB | |
| WHC167 | No plasmid found | |
| WHC171 | No plasmid found | |
| WHC179 | IncFIB, IncFII(K), IncQ1 | |
| WHC181 | IncFIB | |
| WHC182 | IncR, Col | |
| WHC190 | IncHI2A, IncU, Col | |
| WHC192 | IncFIB, repB |
Figure 1Phylogeny of K. pneumoniae isolated based on differences in SNPs.
Figure 2Phylogeny of E. hormaechei isolated based on differences in SNPs.
Antimicrobial Susceptibility Profiles in Enterobacteriaceae (n=125)
| Ag+-R | Ag+-S | P | P | |||
|---|---|---|---|---|---|---|
| n=9 (%) | n=116 (%) | n=24 (%) | n=101 (%) | |||
| Ceftriaxone | 9 (100) | 55 (47.4) | 18 (75) | 46 (45.5) | ||
| Ceftazidime | 9 (100) | 31 (26.7) | 14 (58.3) | 26 (25.7) | ||
| Cefepime | 9 (100) | 19 (16.4) | 9 (37.5) | 19 (18.8) | 0.059 | |
| Aztreonam | 9 (100) | 34 (29.3) | 14 (58.3) | 29 (28.7) | ||
| Imipenem | 8 (88.9) | 9 (7.8) | 4 (16.7) | 13 (12.9) | 0.740 | |
| Meropenem | 8 (88.9) | 8 (6.9) | 4 (16.7) | 12 (11.9) | 0.508 | |
| Amikacin | 0 (0) | 5 (4.3) | 1.000 | 1 (4.2) | 4 (4) | 1.000 |
| Gentamicin | 9 (100) | 32 (27.6) | 12 (50) | 29 (28.7) | 0.055 | |
| Levofloxacin | 7 (77.8) | 34 (29.3) | 8 (33.3) | 33 (32.7) | 1.000 | |
| Ciprofloxacin | 8 (88.9) | 45 (38.8) | 12 (50) | 41 (40.6) | 0.492 | |
| Trimethoprim/sulfamethoxazole | 9 (100) | 54 (46.6) | 15 (62.5) | 48 (47.5) | 0.256 |
Note: Significant differences are indicated in bold font.
In vitro Selection of Ag+ Resistance Mutants of the silS-Positive Strains
| Isolate | Ag+ MIC Parent Strain (μg/mL) | Ag+ MIC Mutant (μg/mL) | Mutation Frequency | Amino Acid Substitution in | Amino Acid Substitution in |
|---|---|---|---|---|---|
| WHC9 | 32 | >512 | 2.2×10−7 | Trp353Arg | No mutation |
| WHC12 | 32 | >512 | 6.06×10−8 | Ala13Thr | No mutation |
| WHC16 | 32 | >512 | 2.86×10−8 | Ala13Thr | No mutation |
| WHC21 | 32 | >512 | Failure | / | / |
| WHC31 | 16 | >512 | 2.08×10−8 | Thr32Ile | No mutation |
| WHC41 | 32 | >512 | 8.39×10−8 | Asp436Val | No mutation |
| WHC49 | 16 | >512 | 1.91×10−8 | Phe249Leu | No mutation |
| WHC57 | 16 | >512 | 3.02×10−8 | Leu322Gln | No mutation |
| WHC61 | 16 | >512 | 1.18×10−8 | Ser196Ile | No mutation |
| WHC65 | 8 | >512 | Failure | / | / |
| WHC151 | 32 | >512 | 3.40×10−8 | Gln351Lys | No mutation |
| WHC152 | 16 | >512 | 3.00×10−8 | Gly210Gln | No mutation |
| WHC160 | 32 | >512 | Failure | / | / |
| WHC161 | 32 | >512 | 3.50×10−8 | Gly210Gln | No mutation |
| WHC167 | 32 | >512 | Failure | / | / |
| WHC171 | 32 | >512 | 7.30×10−8 | No mutation | Asp187Tyr |
| WHC179 | 32 | >512 | 9.8×10−9 | Leu242Gln | No mutation |
| WHC181 | 32 | >512 | 3.75×10−8 | Ser196Ile | No mutation |
| WHC182 | 64 | >512 | 9.28×10−8 | Leu212Pro | No mutation |
| WHC192 | 32 | >512 | Failure | / | / |